PortfoliosLab logo
CFRUY vs. DGX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CFRUY and DGX is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

CFRUY vs. DGX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Compagnie Financiere Richemont (CFRUY) and Quest Diagnostics Incorporated (DGX). The values are adjusted to include any dividend payments, if applicable.

400.00%600.00%800.00%1,000.00%1,200.00%1,400.00%1,600.00%December2025FebruaryMarchAprilMay
1,305.23%
400.60%
CFRUY
DGX

Key characteristics

Sharpe Ratio

CFRUY:

0.87

DGX:

1.43

Sortino Ratio

CFRUY:

1.52

DGX:

2.26

Omega Ratio

CFRUY:

1.20

DGX:

1.27

Calmar Ratio

CFRUY:

1.12

DGX:

1.83

Martin Ratio

CFRUY:

2.90

DGX:

8.59

Ulcer Index

CFRUY:

10.38%

DGX:

3.65%

Daily Std Dev

CFRUY:

34.50%

DGX:

21.98%

Max Drawdown

CFRUY:

-46.33%

DGX:

-49.46%

Current Drawdown

CFRUY:

-14.52%

DGX:

-0.31%

Fundamentals

Market Cap

CFRUY:

$103.49B

DGX:

$19.90B

EPS

CFRUY:

$0.66

DGX:

$7.91

PE Ratio

CFRUY:

26.85

DGX:

22.53

PEG Ratio

CFRUY:

1.79

DGX:

1.58

PS Ratio

CFRUY:

5.06

DGX:

1.95

PB Ratio

CFRUY:

4.60

DGX:

2.87

Returns By Period

In the year-to-date period, CFRUY achieves a 16.45% return, which is significantly lower than DGX's 19.11% return. Over the past 10 years, CFRUY has underperformed DGX with an annualized return of 9.81%, while DGX has yielded a comparatively higher 12.11% annualized return.


CFRUY

YTD

16.45%

1M

5.66%

6M

21.88%

1Y

24.53%

5Y*

29.99%

10Y*

9.81%

DGX

YTD

19.11%

1M

4.80%

6M

15.72%

1Y

32.16%

5Y*

13.01%

10Y*

12.11%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CFRUY vs. DGX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CFRUY
The Risk-Adjusted Performance Rank of CFRUY is 7979
Overall Rank
The Sharpe Ratio Rank of CFRUY is 7979
Sharpe Ratio Rank
The Sortino Ratio Rank of CFRUY is 7676
Sortino Ratio Rank
The Omega Ratio Rank of CFRUY is 7575
Omega Ratio Rank
The Calmar Ratio Rank of CFRUY is 8585
Calmar Ratio Rank
The Martin Ratio Rank of CFRUY is 7777
Martin Ratio Rank

DGX
The Risk-Adjusted Performance Rank of DGX is 8989
Overall Rank
The Sharpe Ratio Rank of DGX is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of DGX is 8888
Sortino Ratio Rank
The Omega Ratio Rank of DGX is 8585
Omega Ratio Rank
The Calmar Ratio Rank of DGX is 9292
Calmar Ratio Rank
The Martin Ratio Rank of DGX is 9393
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CFRUY vs. DGX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Compagnie Financiere Richemont (CFRUY) and Quest Diagnostics Incorporated (DGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for CFRUY, currently valued at 0.87, compared to the broader market-2.00-1.000.001.002.003.00
CFRUY: 0.87
DGX: 1.43
The chart of Sortino ratio for CFRUY, currently valued at 1.52, compared to the broader market-6.00-4.00-2.000.002.004.00
CFRUY: 1.52
DGX: 2.26
The chart of Omega ratio for CFRUY, currently valued at 1.20, compared to the broader market0.501.001.502.00
CFRUY: 1.20
DGX: 1.27
The chart of Calmar ratio for CFRUY, currently valued at 1.12, compared to the broader market0.001.002.003.004.005.00
CFRUY: 1.12
DGX: 1.83
The chart of Martin ratio for CFRUY, currently valued at 2.90, compared to the broader market-40.00-30.00-20.00-10.000.0010.0020.00
CFRUY: 2.90
DGX: 8.59

The current CFRUY Sharpe Ratio is 0.87, which is lower than the DGX Sharpe Ratio of 1.43. The chart below compares the historical Sharpe Ratios of CFRUY and DGX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00December2025FebruaryMarchAprilMay
0.87
1.43
CFRUY
DGX

Dividends

CFRUY vs. DGX - Dividend Comparison

CFRUY's dividend yield for the trailing twelve months is around 1.82%, more than DGX's 1.71% yield.


TTM20242023202220212020201920182017201620152014
CFRUY
Compagnie Financiere Richemont
1.82%2.12%2.86%2.56%1.44%1.56%2.56%3.10%2.05%2.63%2.28%1.66%
DGX
Quest Diagnostics Incorporated
1.71%1.96%2.02%2.08%1.40%1.85%1.99%2.34%1.83%1.72%2.07%1.92%

Drawdowns

CFRUY vs. DGX - Drawdown Comparison

The maximum CFRUY drawdown since its inception was -46.33%, smaller than the maximum DGX drawdown of -49.46%. Use the drawdown chart below to compare losses from any high point for CFRUY and DGX. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%December2025FebruaryMarchAprilMay
-14.52%
-0.31%
CFRUY
DGX

Volatility

CFRUY vs. DGX - Volatility Comparison

Compagnie Financiere Richemont (CFRUY) has a higher volatility of 15.18% compared to Quest Diagnostics Incorporated (DGX) at 9.81%. This indicates that CFRUY's price experiences larger fluctuations and is considered to be riskier than DGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%December2025FebruaryMarchAprilMay
15.18%
9.81%
CFRUY
DGX

Financials

CFRUY vs. DGX - Financials Comparison

This section allows you to compare key financial metrics between Compagnie Financiere Richemont and Quest Diagnostics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B4.00B6.00B8.00B10.00B20212022202320242025
10.41B
2.65B
(CFRUY) Total Revenue
(DGX) Total Revenue
Values in USD except per share items